Candida albicans and Staphylococcus aureus are opportunistic pathogens. Despite causing a number of independent
infections, both pathogens can co-infect to cause
urinary tract infections, skin
infections, biofilm associated
infections,
sepsis and
pneumonia.
Infections of these two pathogens especially their biofilm associated
infections are often difficult to treat using currently available anti-bacterial and
anti-fungal agents. In order to identify a common
anti-microbial agent which could confer a broad range of protection against their
infections, we screened several
phytochemicals and identified
plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), a
phytochemical from Plumbago species as a potent
antimicrobial agent against S. aureus and C. albicans, with a minimum inhibitory concentration of 5μg/ml. Antimicrobial activity of
plumbagin was validated using an ex-vivo porcine skin model. For better understanding of the antimicrobial activity of
plumbagin, a Drosophila melanogaster
infection model was used, where D. melanogaster was infected using S. aureus and C. albicans, or with both organisms. The fly's survival rate was dramatically increased when infected flies were treated using
plumbagin. Further,
plumbagin was effective in preventing and dispersing
catheter associated biofilms formed by these pathogens. The overall results of this work provides evidence that
plumbagin, possesses an excellent antimicrobial activity which should be explored further for the treatment of S. aureus and C. albicans
infections.